Stage II Renal Cell Cancer: Clinical Trials

13 trials for Stage II Renal Cell Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 terminated, 2 recruiting, 1 active not recruiting. 5 Phase 1, 4 Not applicable, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Terminated 2, Recruiting 1
Not applicable4Completed 2, Terminated 1, Withdrawn 1
Phase 24Completed 2, Recruiting 2

Follow Stage II Renal Cell Cancer: new trials by email Literature Review of Stage II Renal Cell Cancer trials Research Report on Stage II Renal Cell Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer
Phase 1 / Phase 2RecruitingJonsson Comprehensive Cancer Center252024-12-262026-08-21
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer
Biospecimen Collection, Bone Scan, Computed Tomography - Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma
Phase 2RecruitingJonsson Comprehensive Cancer Center912024-08-062026-06-15
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Interstitial Radiation Therapy - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer
Phase 1TerminatedJonsson Comprehensive Cancer Center22020-07-162026-08-20
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma
Phase 1TerminatedUniversity of Southern California22016-08-022021-11-24
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Computed Tomography, Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Healthy Subject, Metastatic Renal Cell Cancer
Active not recruitingUniversity of Southern California372015-09-082026-04-02
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
Arterial Spin Labeling Magnetic Resonance Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer
Not applicableCompletedRutgers, The State University of New Jersey752015-04-012026-06-02
Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer
Laboratory Biomarker Analysis, Nephrectomy, Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003 - Recurrent Renal Cell Carcinoma, Stage I Renal Cell Cancer
Not applicableTerminatedRoswell Park Cancer Institute52014-10-142020-07-07
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Not applicableCompletedCity of Hope Medical Center2002013-10-292026-10-01
Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
tivozanib, therapeutic conventional surgery - Stage II Renal Cell Cancer, Stage III Renal Cell Cancer
Not applicableWithdrawnRoswell Park Cancer Institute2013-03-142022-08-15
Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors
fluorescence imaging, laparoscopic surgery, indocyanine green - Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer
Phase 1CompletedCity of Hope Medical Center282011-10-202017-10-13
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
sunitinib malate, bevacizumab, pharmacological study - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer
Phase 1CompletedNational Cancer Institute (NCI)62010-10-012014-04-02
Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
pazopanib hydrochloride, therapeutic conventional surgery - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer
Phase 2CompletedCase Comprehensive Cancer Center252010-06-012018-09-12
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Doxorubicin Hydrochloride, Irinotecan Hydrochloride, Conventional Surgery - Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma
Phase 2CompletedChildren's Oncology Group2912006-06-012017-07-21

Narrower conditions

Carcinoma, Renal Cell (13)  ·  Urinary Bladder Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colonic Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Stomach Neoplasms (1)  ·  Ureteral Neoplasms (1)  ·  Urethral Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Wilms Tumor (1)

Broader conditions

Adenocarcinoma (13)  ·  Carcinoma (13)  ·  Female Urogenital Diseases (13)  ·  Female Urogenital Diseases and Pregnancy Complications (13)  ·  Kidney Diseases (13)  ·  Kidney Neoplasms (13)  ·  Male Urogenital Diseases (13)  ·  Neoplasms (13)  ·  Neoplasms by Histologic Type (13)  ·  Neoplasms by Site (13)  ·  Neoplasms, Glandular and Epithelial (13)  ·  Urogenital Diseases (13)  ·  Urogenital Neoplasms (13)  ·  Urologic Diseases (13)  ·  Urologic Neoplasms (13)

Interventions

Magnetic Resonance Spectroscopy (3)  ·  Specimen Handling (2)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Bevacizumab (1)  ·  Brachytherapy (1)  ·  Carboplatin (1)  ·  Congresses as Topic (1)  ·  Cyclophosphamide (1)  ·  Cystectomy (1)  ·  Dactinomycin (1)  ·  Doxorubicin (1)  ·  Early Intervention, Educational (1)  ·  Etoposide (1)  ·  Indocyanine Green (1)  ·  Irinotecan (1)

Sponsors

Jonsson Comprehensive Cancer Center (3)  ·  City of Hope Medical Center (2)  ·  Roswell Park Cancer Institute (2)  ·  University of Southern California (2)  ·  Case Comprehensive Cancer Center (1)  ·  Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (12)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Puerto Rico (1)

Top investigators

Albert J Chang (1)  ·  Betty Ferrell (1)  ·  Brian Rini (1)  ·  Brian Shuch (1)  ·  Clayton Lau, MD (1)  ·  David Foran (1)  ·  David I Quinn, MD (1)  ·  Glenn Liu (1)  ·  Jacek Pinski, MD (1)  ·  Jeffrey Dome, MD (1)  ·  Saby George (1)  ·  Siddharth A Padia (1)

Results publications

PMID 25532471, PMID 38396300, PMID 41276366

NIH funding

P30CA014089 (2), P30CA014520 (1), P30CA016056 (1), P30CA072720 (1), U01CA062491 (1), U01CA070095 (1), U10CA098543 (1)